Ascidian Therapeutics

FDA Clears Ascidian for First-Ever RNA Editing Trial in US
BioSpace
Tue, 01/30/24 - 09:22 pm
Ascidian Therapeutics
FDA
clinical trials
Stargardt disease
RNA editing
Sea creature-inspired biotech Ascidian surfaces with $50M and a new way to edit RNA
MedCity News
Wed, 10/12/22 - 10:32 am
Ascidian Therapeutics
RNA
Stargardt disease
funding